Ecstasy trials approved by FDA for PTSD patients

Turns out, Ecstasy could have some medicinal value.

After successful preliminary trials, the FDA is moving forward with a large scale study for using Ecstasy as a prescription drug to treat post-traumatic stress disorder.

The study approved on Tuesday would be the final measure necessary before the agency could legalize the drug, according to the New York Times. If the results are favorable, the drug also known as MDMA would be available to patients as early as 2021.

The trial, sponsored by the Multidisciplinary Association for Psychedelic Studies, reportedly will include 230 participants. Past research funded by the organization has studied the drug’s effect on veterans, sexual assault victims, police and firefighters suffering from PTSD.


Categories: Politics